Cholinesterase Inhibitors: Drugs Looking for a Disease?
Author Information
Author(s): Marina Maggini, Nicola Vanacore, Roberto Raschetti
Primary Institution: National Center for Epidemiology, National Institute of Health, Rome, Italy
Hypothesis
What is the evidence for the effectiveness of cholinesterase inhibitors in treating dementia?
Conclusion
Cholinesterase inhibitors have not led to proven improvements in patients' well-being despite their use in treating dementia.
Supporting Evidence
- Cholinesterase inhibitors have been shown to have modest effects in clinical trials.
- The efficacy of these drugs is often presented in a way that may create a false perception of their effectiveness.
- Many trials used unvalidated scales for measuring outcomes, which undermines their clinical relevance.
- The NICE committee concluded that the evidence for the effectiveness of cholinesterase inhibitors is limited and inconclusive.
Takeaway
Doctors are using certain drugs to help people with dementia, but they don't really work as well as we hoped.
Methodology
The article reviews randomized controlled trials and systematic reviews of cholinesterase inhibitors for dementia.
Potential Biases
There are concerns about selection bias, measurement bias, and attrition bias in the reviewed trials.
Limitations
Many trials had restrictive inclusion criteria and did not represent the general patient population.
Participant Demographics
The studies included patients with various types of dementia, including Alzheimer's disease and vascular dementia.
Statistical Information
Confidence Interval
95% confidence interval, 4%–17%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website